Comparison between Novus Loyalty IPO and Q-Line Biotec IPO.
Novus Loyalty IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Q-Line Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
| Novus Loyalty IPO | Q-Line Biotec IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Smart Horizon Capital Advisors Pvt.Ltd. | Share India Capital Services Pvt.Ltd. Hem Securities Ltd. |
| Registrar | Kfin Technologies Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Novus Loyalty IPO is up to ₹56.79 Cr whereas the issue size of the Q-Line Biotec IPO is up to ₹203.74 Cr. The final issue price of Novus Loyalty IPO is ₹146.00 per share and of Q-Line Biotec IPO is ₹343.00 per share.
| Novus Loyalty IPO | Q-Line Biotec IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹139.00 per share | ₹326.00 per share |
| Issue Price (Upper) | ₹146.00 per share | ₹343.00 per share |
| Issue Price (Final) | ₹146.00 per share | ₹343.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 400 shares |
| Fresh Issue Size | 30,70,000 shares | 59,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹44.82 Cr | up to ₹203.74 Cr |
| OFS Issue Size | 8,20,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹11.97 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,90,000 shares | 59,40,000 shares |
| Issue Size Total (Amount) | up to ₹56.79 Cr | up to ₹203.74 Cr |
Novus Loyalty IPO opens on Mar 17, 2026, while Q-Line Biotec IPO opens on May 21, 2026. The closing date of Novus Loyalty IPO and Q-Line Biotec IPO is Mar 20, 2026, and May 25, 2026, respectively.
| Novus Loyalty IPO | Q-Line Biotec IPO | |
|---|---|---|
| Anchor Bid Date | Mar 16, 2026 | May 20, 2026 |
| Issue Open | Mar 17, 2026 | May 21, 2026 |
| Issue Close | Mar 20, 2026 | May 25, 2026 |
| Basis Of Allotment (Tentative) | Mar 23, 2026 | May 26, 2026 |
| Initiation of Refunds (Tentative) | Mar 24, 2026 | May 27, 2026 |
| Credit of Share (Tentative) | Mar 24, 2026 | May 27, 2026 |
| Listing date (Tentative) | Mar 25, 2026 | May 29, 2026 |
| Anchor Lockin End date 1 | Apr 22, 2026 | Jun 25, 2026 |
| Anchor Lockin End date 2 | Jun 21, 2026 | Aug 24, 2026 |
Novus Loyalty IPO P/E ratio is 49.89, as compared to Q-Line Biotec IPO P/E ratio of 20.82.
| Novus Loyalty IPO | Q-Line Biotec IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.62 | 96.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 49.89 | 20.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹227.03 Cr. | ₹800.16 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 31.74 | 23.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 40.40 | 17.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.93 | ₹16.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.39 | 23.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Novus Loyalty IPO Retail Individual Investors (RII) are offered 13,64,000 shares while in Q-Line Biotec IPO retail investors are offered 13,64,000 shares. Qualified Institutional Buyers (QIB) are offered 8,10,000 shares in Novus Loyalty IPO and 11,88,000 shares in Q-Line Biotec IPO.
| Novus Loyalty IPO | Q-Line Biotec IPO | |
|---|---|---|
| Anchor Investor Reservation | 11,30,000 shares | 17,81,200 shares |
| Market Maker Reservation | 2,30,000 shares | 3,13,200 shares |
| QIB | 8,10,000 shares | 11,88,000 shares |
| NII | 5,86,000 shares | 8,91,600 shares |
| RII | 13,64,000 shares | 20,79,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 38,90,000 shares | 59,40,000 shares |
Novus Loyalty IPO subscribed 1.10x in total, whereas Q-Line Biotec IPO subscribed 71.71x.
| Novus Loyalty IPO | Q-Line Biotec IPO | |
|---|---|---|
| QIB (times) | 1.38x | 123.94x |
| NII (times) | 1.17x | 145.98x |
| Big NII (times) | 1.31x | 178.29x |
| Small NII (times) | 0.88x | 81.35x |
| RII (times) | 1.82x | 71.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.10x | 71.71x |
